Literature DB >> 21297657

Is 37LRP cell surface receptor for PSP94?

Bhakti R Pathak, Dhanshree D Jagtap, Smita D Mahale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21297657      PMCID： PMC3739215          DOI： 10.1038/aja.2010.185

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  6 in total

1.  Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.

Authors:  Aleyde Van Eynde; Kirill Litovkin; Mathieu Bollen
Journal:  Asian J Androl       Date:  2010-11-22       Impact factor: 3.285

2.  Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.

Authors:  Borhane Annabi; Jean-Christophe Currie; Mounia Bouzeghrane; Hélène Dulude; Luc Daigneault; Seema Garde; Shafaat A Rabbani; Chandra Panchal; Jinzi J Wu; Richard Béliveau
Journal:  Biochem Biophys Res Commun       Date:  2006-06-02       Impact factor: 3.575

3.  Identification of binding proteins for PSP94 in human prostate adenocarcinoma cell lines LNCaP and PC-3.

Authors:  J P Yang; M Baijal-Gupta; S V Garde; J E Fraser; M A Finkelman; M W Clarke
Journal:  Prostate       Date:  1998-04-01       Impact factor: 4.104

4.  Evidence for the presence of specific receptors for inhibin in human prostate.

Authors:  M Phadke; S Vijayalakshmi; A R Sheth
Journal:  Indian J Exp Biol       Date:  1982-05       Impact factor: 0.818

5.  A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.

Authors:  Sylvie Lamy; Marcia T Ruiz; Jan Wisniewski; Seema Garde; Shafaat A Rabbani; Chandra Panchal; Jinzi J Wu; Borhane Annabi
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

6.  Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.

Authors:  Borhane Annabi; Mounia Bouzeghrane; Jean-Christophe Currie; Hélène Dulude; Luc Daigneault; Seema Garde; Shafaat A Rabbani; Chandra Panchal; Jinzi J Wu; Richard Béliveau
Journal:  Anticancer Drugs       Date:  2006-04       Impact factor: 2.248
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.